The prospective study of weekly Paclitaxel and Carboplatin for elderly patients with gynecologic cancer

The prospective study of weekly Paclitaxel and Carboplatin for elderly patients with gynecologic cancer - Weekly TC for elderly patients

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000028336

Enrollment

Registered

2017-07-25

Start date

2017-07-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients older than 75 years old with gynecologic cancer who are administered Paclitaxel and Carboplatin

Interventions

Patients who are older than 75 years with gynecologic cancers

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Older than 75 years old Diagnosed Gynecologic cancer Adaptation for chemotherapy of TC rejimen

Exclusion criteria

Exclusion criteria: Performance status is under 3

Design outcomes

Primary

Measure	Time frame
The degree of accomplishment in 6 courses	—

Secondary

Measure	Time frame
Profression free survival in 2 years	—

Countries

Japan

Contacts

Public ContactSatoe Fujiwara

Osaka Medical College Obsterics and Gunecology

gyn092@osaka-med.ac.jp072-683-1221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026